Transformational Growth Driven by Disruptive AI Solutions Enhancing Workflow Efficiency and Clinical Decision-Making
This study examines the role of artificial intelligence (AI) in the global mammography market. The high prevalence of breast cancer in women has increased the demand for breast cancer screening, which, in turn, heightened the focus on using AI-based solutions for mammography. AI solutions can reduce results variability among radiologists and improve breast cancer detection rates. They also play a pivotal role in decreasing radiologists’ workloads and boosting the affordability and accuracy of breast cancer screening programs.
The study outlines the key trends emerging in the AI and mammography space and profiles notable providers and solutions in three core mammography functions: Image analysis, triage, and clinical decision support. The study also guides technology vendors in charting their strategic priorities and building new capabilities to capitalize on emerging growth opportunities in the mammography space.
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- iCAD
- Lunit
- RadNet
- Volpara Health
- Whiterabbit.ai
- Densitas
- Hologic
- Therapixel
- Kheiron
- ScreenPoint Medical
- Siemens Healthineers
- CureMetrix